Wide-Angle Circular Polarization Converter Based on a Metasurface of Z-Shaped Unit Cells

Por Mingjun Wang, Mingjun Wang, Mingjun Wang, Zhizhu Zhai
Publicado em 2020-10-01

Asymmetric Inner-Core Structure and its Impact on Rapid Intensification of a Sheared Tropical Cyclone

Por Bojun Liu, Mingjun Wang, Kun Zhao, Kun Zhao
Publicado em 2022-04-01

Learning Long-range Terrain Perception for Autonomous Mobile Robots

Por Mingjun Wang, Jun Zhou, Jun Tu, Chengliang Liu
Publicado em 2010-03-01

TANGLE: two-level support vector regression approach for protein backbone torsion angle prediction from primary sequences.

Por Jiangning Song, Hao Tan, Mingjun Wang, Geoffrey I Webb, Tatsuya Akutsu
Publicado em 2012-01-01

Prediction of flow boiling heat transfer coefficient in horizontal channels varying from conventional to small-diameter scales by genetic neural network

Por Jing Zhang, Yichao Ma, Mingjun Wang, Dalin Zhang, Suizheng Qiu, Wenxi Tian, Guanghui Su
Publicado em 2019-12-01

A Sustainable Approach to the Preparation of MoO₂ Quantum Dots and the Pseudocapacitive Performance before and after Calcination

Por Yi An, Weizhi Gong, Junli Wang, Jianlin Liu, Liexing Zhou, Yi Xia, Cheng Pan, Mingjun Wang, Dong Fang
Publicado em 2022-04-01

Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells.

Por Yukiko Kiniwa, Jiang Li, Mingjun Wang, Chuang Sun, Jeffrey E Lee, Rong-Fu Wang, Helen Y Wang
Publicado em 2015-01-01

CFD simulation of flow and heat transfer characteristics in a 5×5 fuel rod bundles with spacer grids of advanced PWR

Por Yingjie Wang, Mingjun Wang, Haoran Ju, Minfu Zhao, Dalin Zhang, Wenxi Tian, Tiancai Liu, Suizheng Qiu, G.H. Su
Publicado em 2020-07-01

Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.

Por Satoko Matsueda, Mingjun Wang, Jinsheng Weng, Ying Li, Bingnan Yin, Jia Zou, Qingtian Li, Wei Zhao, Weiyi Peng, Xavier Legras, Christopher Loo, Rong-Fu Wang, Helen Y Wang
Publicado em 2012-01-01

Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years

Por Damon Bass, Regina Kurrasch, Yin Su, Jie Zheng, Yang Li, Guochun Wang, Fengchun Zhang, David A Roth, Jieruo Gu, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik, Mingjun Wang, Xingfu Li
Publicado em 2022-04-01